In this regard, it has been reported that post-COVID-19 patients develop a cytokine syndrome characterized by an imbalance of pro-inflammatory and anti-inflammatory cytokines, such as IL-17 and IL-2, and IL-10 and IL-4, compared with COVID-19 patients without sequelae [99]. This evidence concerns the gene IL17A and COVID-19.